Met Life Investment Management, LLC Vericel Corp Transaction History

Met Life Investment Management, LLC

  • $18.1 Billion
  • Q1 2025

A detailed history of Met Life Investment Management, LLC transactions in Vericel Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 29,187 shares of VCEL stock, worth $1.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
29,187
Previous 29,609 1.43%
Holding current value
$1.23 Million
Previous $1.63 Million 19.88%
% of portfolio
0.01%
Previous 0.01%

Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$44.5 - $61.8 $18,779 - $26,079
-422 Reduced 1.43%
29,187 $1.3 Million
Q4 2024

Feb 13, 2025
BUY
$40.05 - $59.11 $77,256 - $114,023
1,929 Added 6.97%
29,609 $1.63 Million
Q2 2024

Aug 13, 2024
BUY
$41.71 - $52.9 $135,223 - $171,501
3,242 Added 13.27%
27,680 $1.27 Million
Q1 2024

May 14, 2024
BUY
$32.52 - $52.33 $794,723 - $1.28 Million
24,438 New
24,438 $1.27 Million
Q3 2023

May 09, 2024
BUY
$31.69 - $39.25 $20,788 - $25,748
656 Added 2.57%
26,207 $878,000
Q2 2023

Apr 29, 2024
BUY
$29.0 - $38.37 $760,003 - $1.01 Million
26,207 New
26,207 $984,000
Q2 2023

Aug 10, 2023
BUY
$29.0 - $38.37 $19,024 - $25,170
656 Added 2.57%
26,207 $984,000
Q1 2023

May 09, 2024
BUY
$23.85 - $31.34 $609,391 - $800,768
25,551 New
25,551 $749 Million
Q4 2022

May 10, 2024
SELL
$17.65 - $27.37 $15,814 - $24,523
-896 Reduced 3.39%
25,551 $673,000
Q4 2022

Mar 22, 2023
SELL
$17.65 - $27.37 $15,814 - $24,523
-896 Reduced 3.39%
25,551 $673,000
Q4 2022

Feb 15, 2023
SELL
$17.65 - $27.37 $15,814 - $24,523
-896 Reduced 3.39%
25,551 $673,000
Q3 2022

Jun 14, 2023
BUY
$22.62 - $32.54 $20,267 - $29,155
896 Added 3.51%
26,447 $613,000
Q2 2022

Jun 20, 2023
BUY
$22.88 - $39.45 $20,500 - $35,347
896 Added 3.51%
26,447 $665,000
Q1 2022

May 10, 2024
BUY
$31.69 - $43.29 $838,105 - $1.14 Million
26,447 New
26,447 $1.01 Million
Q1 2022

Jun 20, 2023
BUY
$31.69 - $43.29 $28,394 - $38,787
896 Added 3.51%
26,447 $1.01 Million
Q1 2022

Mar 22, 2023
BUY
$31.69 - $43.29 $307,931 - $420,648
9,717 Added 58.08%
26,447 $1.01 Million
Q1 2022

May 12, 2022
BUY
$31.69 - $43.29 $307,931 - $420,648
9,717 Added 58.08%
26,447 $1.01 Million
Q4 2021

Jun 21, 2023
SELL
$35.2 - $52.6 $310,499 - $463,984
-8,821 Reduced 34.52%
16,730 $657,000
Q3 2021

Jun 21, 2023
SELL
$46.35 - $59.75 $408,853 - $527,054
-8,821 Reduced 34.52%
16,730 $816,000
Q2 2021

May 17, 2024
SELL
$47.2 - $67.81 $89,774 - $128,974
-1,902 Reduced 10.21%
16,730 $878,000
Q2 2021

Jun 21, 2023
SELL
$47.2 - $67.81 $416,351 - $598,152
-8,821 Reduced 34.52%
16,730 $878,000
Q2 2021

Mar 22, 2023
SELL
$47.2 - $67.81 $89,774 - $128,974
-1,902 Reduced 10.21%
16,730 $878,000
Q2 2021

Aug 16, 2021
SELL
$47.2 - $67.81 $89,774 - $128,974
-1,902 Reduced 10.21%
16,730 $878,000
Q1 2021

May 17, 2024
SELL
$30.93 - $59.48 $179,579 - $345,340
-5,806 Reduced 23.76%
18,632 $1.04 Million
Q1 2021

Jun 26, 2023
SELL
$30.93 - $59.48 $214,004 - $411,542
-6,919 Reduced 27.08%
18,632 $1.04 Billion
Q4 2020

Jun 22, 2023
SELL
$18.53 - $31.5 $128,209 - $217,948
-6,919 Reduced 27.08%
18,632 $575,000
Q3 2020

Jun 26, 2023
SELL
$14.68 - $19.12 $101,570 - $132,291
-6,919 Reduced 27.08%
18,632 $345,000
Q2 2020

May 24, 2024
SELL
$8.5 - $15.82 $49,351 - $91,850
-5,806 Reduced 23.76%
18,632 $257 Million
Q2 2020

Jun 26, 2023
SELL
$8.5 - $15.82 $58,811 - $109,458
-6,919 Reduced 27.08%
18,632 $257,000
Q1 2020

Jul 12, 2023
SELL
$7.25 - $19.22 $50,162 - $132,983
-6,919 Reduced 27.08%
18,632 $170,000
Q4 2019

Jul 12, 2023
SELL
$13.77 - $19.2 $95,274 - $132,844
-6,919 Reduced 27.08%
18,632 $324,000
Q3 2019

Jul 12, 2023
SELL
$14.93 - $19.83 $103,300 - $137,203
-6,919 Reduced 27.08%
18,632 $282,000
Q2 2019

Jul 12, 2023
SELL
$15.01 - $18.89 $103,854 - $130,699
-6,919 Reduced 27.08%
18,632 $351,000
Q1 2019

Jul 13, 2023
SELL
$16.23 - $20.29 $112,295 - $140,386
-6,919 Reduced 27.08%
18,632 $326,000
Q4 2018

Jul 13, 2023
SELL
$10.77 - $18.44 $74,517 - $127,586
-6,919 Reduced 27.08%
18,632 $324,000
Q4 2018

Mar 22, 2023
SELL
$10.77 - $18.44 $110,683 - $189,507
-10,277 Reduced 35.55%
18,632 $324,000
Q4 2018

Feb 14, 2019
SELL
$10.77 - $18.44 $110,683 - $189,507
-10,277 Reduced 35.55%
18,632 $324,000
Q3 2018

Jul 13, 2023
SELL
$9.1 - $14.8 $62,962 - $102,401
-6,919 Reduced 27.08%
18,632 $263,000
Q3 2018

Mar 22, 2023
BUY
$9.1 - $14.8 $30,557 - $49,698
3,358 Added 13.14%
28,909 $409,000
Q3 2018

Nov 14, 2018
BUY
$9.1 - $14.8 $93,520 - $152,099
10,277 Added 55.16%
28,909 $409,000
Q2 2018

Aug 15, 2018
BUY
$9.6 - $14.6 $178,867 - $272,027
18,632 New
18,632 $181,000

Others Institutions Holding VCEL

# of Institutions
291
Shares Held
52.1M
Call Options Held
36.7K
Put Options Held
6.4K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $1.98B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email